Search

NeoGenomics Inc

Open

SectorHealthcare

19.17 0.37

Overview

Share price change

24h

Current

Min

18.71

Max

19.32

Key metrics

By Trading Economics

Income

19M

2.2M

Sales

15M

202M

EPS

-0.01

Profit margin

1.11

Employees

2,500

EBITDA

19M

19M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-2.95% downside

Dividends

By Acuity

Next Earnings

27 paź 2026

Market Stats

By TradingEconomics

Market Cap

654M

2.4B

Previous open

18.8

Previous close

19.17

News Sentiment

By Acuity

76%

24%

304 / 339 Ranking in Healthcare

NeoGenomics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 wrz 2026, 20:07 UTC

Neogenomics Inc's shares are higher today, reflecting a notable increase since Monday's close. The stock remains above its 20-day moving average.

14 wrz 2026, 23:46 UTC

Neogenomics Inc shares are modestly higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

11 wrz 2026, 21:01 UTC

Neogenomics Inc shares declined in after-market trading, coinciding with a significant drop in the Michigan Consumer Sentiment Index. No specific company news was identified.

10 wrz 2026, 20:07 UTC

Neogenomics Inc shares are lower today amid a broader market decline and rising Treasury yields, with no specific company news identified.

9 wrz 2026, 20:07 UTC

Neogenomics Inc's shares are higher Wednesday, despite an earlier pullback. No specific company news was identified to explain the price movement.

8 wrz 2026, 19:26 UTC

Neogenomics Inc shares are higher today, continuing gains since Friday. The stock remains above its 20-day moving average and within its one-month range.

4 wrz 2026, 23:20 UTC

Neogenomics Inc shares are higher in after-market trading, reflecting strong performance since Friday's close and positioning above its 20-day moving average.

2 wrz 2026, 20:08 UTC

Neogenomics Inc is lower in Wednesday's session, continuing a trend of four consecutive declines. No specific news was identified to explain the move.

1 wrz 2026, 20:08 UTC

Neogenomics Inc shares are lower today, continuing a downward trend since Monday. No specific company news was identified to explain the decline.

31 sie 2026, 20:07 UTC

Social Media

Neogenomics Inc shares are lower amid rising interest rate hike expectations following recent economic commentary. Earlier, the stock rebounded from a session high.

28 sie 2026, 20:51 UTC

Neogenomics Inc's shares are higher in after-market hours, moving significantly above their 20-day moving average and near the upper end of their one-month range.

27 sie 2026, 23:01 UTC

Neogenomics Inc. shares are higher in after-market trading, reflecting notable strength following Thursday's close. The stock remains above its 20-day moving average.

26 sie 2026, 23:01 UTC

News

Neogenomics Inc secures expanded Medicare coverage for RaDaR ST assay, enhancing immunotherapy monitoring. Shares are trading higher in after-market hours.

25 sie 2026, 23:02 UTC

Neogenomics Inc is trading higher in after-market hours, remaining near the upper end of its one-month range and above its 20-day moving average.

24 sie 2026, 23:06 UTC

Neogenomics Inc shares are lower in after-market trading, with no specific news identified. Broader market concerns include the U.S.-Iran conflict and oil supply disruptions.

21 sie 2026, 20:06 UTC

Neogenomics shares are higher, benefiting from a strong trend in the Health Care Services sub-sector, despite no specific company news identified.

20 sie 2026, 21:26 UTC

Neogenomics Inc's shares are higher in after-market trading, maintaining a stable performance since Thursday's close amid no specific news or developments.

19 sie 2026, 19:26 UTC

Neogenomics Inc shares are higher today amid strong buying interest. The stock is approaching the upper end of its one-month trading range.

18 sie 2026, 19:36 UTC

Neogenomics Inc shares are lower today amid broader economic concerns, including rising treasury yields and inflation pressures. The stock reached a session low earlier.

17 sie 2026, 22:01 UTC

Neogenomics Inc is rising in after-market trading, reflecting a strong performance following Monday's close amid a generally positive trading environment and heightened volatility.

14 sie 2026, 23:01 UTC

Neogenomics Inc shares are lower in after-market hours, following a decline influenced by mixed market sentiment and a drop in U.S. retail sales.

13 sie 2026, 22:02 UTC

Neogenomics Inc. shares fell in after-market trading, declining since Thursday's close, despite broader market averages closing higher earlier in the day.

12 sie 2026, 23:51 UTC

Neogenomics Inc shares are higher in after-market trading, maintaining a strong upward trajectory since Wednesday's close, despite no specific news identified.

11 sie 2026, 19:26 UTC

Neogenomics Inc. shares are lower today, with no specific news identified. Investors await U.S. inflation reports that may impact market sentiment.

10 sie 2026, 22:26 UTC

Neogenomics Inc shares are higher in after-market trading, remaining above their 20-day moving average despite no specific news. Rising Treasury yields may influence sentiment.

7 sie 2026, 20:03 UTC

Neogenomics Inc shares are higher during Friday's session, reflecting strong market performance. The stock has advanced since Thursday's close, despite a recent pullback.

6 sie 2026, 21:51 UTC

Neogenomics Inc shares are higher in after-market trading, reaching a notable high and remaining above their 20-day moving average. No specific news was identified.

5 sie 2026, 19:36 UTC

Neogenomics Inc shares are lower today, reversing earlier gains despite no specific news. Broader market sentiment reflects easing inflation concerns amid declining crude oil prices.

4 sie 2026, 19:33 UTC

Social Media

Neogenomics Inc. shares are higher amid social media discussions on long-term investment strategies, despite negative narratives about the company's performance.

3 sie 2026, 20:03 UTC

Neogenomics Inc shares are higher today, reflecting overall market momentum. The S&P 500 and Nasdaq 100 also posted gains during the session.

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

-2.95% downside

12 Months Forecast

Average 18.333 USD  -2.95%

High 21 USD

Low 16 USD

Based on 8 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Sentiment

By Acuity

304 / 339 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat